Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children

Background: Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was previously shown to be immunogenic and well tolerated in Malian children. Data on booster vaccination with a fourth consecutive dose of PHiD-CV are available...

Full description

Bibliographic Details
Main Authors:	Dicko, Alassane, Santara, Gaoussou, Mahamar, Almahamoudou, Sidibe, Youssoufa, Barry, Amadou, Dicko, Yahia, Diallo, Aminata, Dolo, Amagana, Doumbo, Ogobara, Shafi, Fakrudeen, François, Nancy, Strezova, Ana, Borys, Dorota, Schuerman, Lode
Format:	Online
Language:	English
Published:	Landes Bioscience 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859761/

id	pubmed-3859761
recordtype	oai_dc
spelling	pubmed-38597612013-12-16 Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children Dicko, Alassane Santara, Gaoussou Mahamar, Almahamoudou Sidibe, Youssoufa Barry, Amadou Dicko, Yahia Diallo, Aminata Dolo, Amagana Doumbo, Ogobara Shafi, Fakrudeen François, Nancy Strezova, Ana Borys, Dorota Schuerman, Lode Research Paper Background: Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was previously shown to be immunogenic and well tolerated in Malian children. Data on booster vaccination with a fourth consecutive dose of PHiD-CV are available for Europe, Asia and Latin America but are lacking for Africa. The present study evaluated further the safety, reactogenicity and immunogenicity of a fourth consecutive (booster) dose of PHiD-CV. Landes Bioscience 2013-02-01 2013-01-04 /pmc/articles/PMC3859761/ /pubmed/23291945 http://dx.doi.org/10.4161/hv.22692 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Dicko, Alassane Santara, Gaoussou Mahamar, Almahamoudou Sidibe, Youssoufa Barry, Amadou Dicko, Yahia Diallo, Aminata Dolo, Amagana Doumbo, Ogobara Shafi, Fakrudeen François, Nancy Strezova, Ana Borys, Dorota Schuerman, Lode
spellingShingle	Dicko, Alassane Santara, Gaoussou Mahamar, Almahamoudou Sidibe, Youssoufa Barry, Amadou Dicko, Yahia Diallo, Aminata Dolo, Amagana Doumbo, Ogobara Shafi, Fakrudeen François, Nancy Strezova, Ana Borys, Dorota Schuerman, Lode Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
author_facet	Dicko, Alassane Santara, Gaoussou Mahamar, Almahamoudou Sidibe, Youssoufa Barry, Amadou Dicko, Yahia Diallo, Aminata Dolo, Amagana Doumbo, Ogobara Shafi, Fakrudeen François, Nancy Strezova, Ana Borys, Dorota Schuerman, Lode
author_sort	Dicko, Alassane
title	Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
title_short	Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
title_full	Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
title_fullStr	Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
title_full_unstemmed	Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
title_sort	safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine (phid-cv) in malian children
description	Background: Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was previously shown to be immunogenic and well tolerated in Malian children. Data on booster vaccination with a fourth consecutive dose of PHiD-CV are available for Europe, Asia and Latin America but are lacking for Africa. The present study evaluated further the safety, reactogenicity and immunogenicity of a fourth consecutive (booster) dose of PHiD-CV.
publisher	Landes Bioscience
publishDate	2013
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859761/
_version_	1612037551059632128

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children

Similar Items